BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 1966999)

  • 1. Increased number of suppressor T-cells and impaired IL-2 mediated T-cell function in peripheral blood of gastric cancer patients.
    Tsubono M; Nio Y; Shiraishi T; Morimoto H; Tseng CC; Kawabata K; Masai Y; Fukumoto M; Tobe T
    J Clin Lab Immunol; 1990 Nov; 33(3):107-15. PubMed ID: 1966999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers.
    Ichihara F; Kono K; Takahashi A; Kawaida H; Sugai H; Fujii H
    Clin Cancer Res; 2003 Oct; 9(12):4404-8. PubMed ID: 14555512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression.
    Shen LS; Wang J; Shen DF; Yuan XL; Dong P; Li MX; Xue J; Zhang FM; Ge HL; Xu D
    Clin Immunol; 2009 Apr; 131(1):109-18. PubMed ID: 19153062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of CD4+CD25high regulatory T-cells in tumor-draining lymph nodes in patients with gastric cancer.
    Kawaida H; Kono K; Takahashi A; Sugai H; Mimura K; Miyagawa N; Omata H; Ooi A; Fujii H
    J Surg Res; 2005 Mar; 124(1):151-7. PubMed ID: 15734494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The increase of CD57+ T cells in the peripheral blood and their impaired immune functions in patients with advanced gastric cancer.
    Chochi K; Ichikura T; Majima T; Kawabata T; Matsumoto A; Sugasawa H; Kawarabayashi N; Takayama E; Hiraide H; Seki S; Mochizuki H
    Oncol Rep; 2003; 10(5):1443-8. PubMed ID: 12883721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Significance of human Tr cell in gastric cancer --with special reference to suppressor cell activity].
    Itagaki E; Toge T; Tanada M; Hamamoto S; Seto Y; Kohno H; Hattori T
    Gan To Kagaku Ryoho; 1984 Jan; 11(1):123-9. PubMed ID: 6230053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The relationship between serum immunosuppressive acidic protein (IAP) and cellular immunity in the patients with gastric cancer].
    Nakanishi K; Toge T; Hamamoto S; Tanada M; Itagaki E; Kohno H; Yanagawa E; Hattori T
    Gan To Kagaku Ryoho; 1982 Oct; 9(10):1827-31. PubMed ID: 6223588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
    Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
    Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.
    Terzieva V; Popova D; Kicheva M; Todorova Y; Markova R; Martinova F; Elenkov I; Yankova M
    Int Immunopharmacol; 2009 Jul; 9(7-8):831-6. PubMed ID: 19303058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyporesponsiveness of T cell subsets after cardiac surgery: a product of altered cell function or merely a result of absolute cell count changes in peripheral blood?
    Franke A; Lante W; Kurig E; Zöller LG; Weinhold C; Markewitz A
    Eur J Cardiothorac Surg; 2006 Jul; 30(1):64-71. PubMed ID: 16730447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Search for immunomodulatory effects of blood transfusion in gastric cancer patients: flow cytometry of Th1/Th2 cells in peripheral blood.
    Sun CF; Hsieh YY; Ngan KW; Wang WT
    Ann Clin Lab Sci; 2001 Apr; 31(2):171-8. PubMed ID: 11337907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
    Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
    Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the spleen in immunosuppression of gastric cancer: predominance of suppressor precursor and suppressor inducer T cells in the recirculating spleen cells.
    Toge T; Kuroi K; Kuninobu H; Yamaguchi Y; Kegoya Y; Baba N; Hattori T
    Clin Exp Immunol; 1988 Dec; 74(3):409-12. PubMed ID: 2976622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose interleukin-2 administered pre-operatively to patients with gastric cancer activates peripheral and peritumoral lymphocytes but does not affect prognosis.
    Cesana GC; Romano F; Piacentini G; Scotti M; Brenna A; Bovo G; Vaghi M; Aletti G; Caprotti R; Kaufman H; Uggeri F
    Ann Surg Oncol; 2007 Apr; 14(4):1295-304. PubMed ID: 17225981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase of regulatory T cells in the peripheral blood of cancer patients.
    Wolf AM; Wolf D; Steurer M; Gastl G; Gunsilius E; Grubeck-Loebenstein B
    Clin Cancer Res; 2003 Feb; 9(2):606-12. PubMed ID: 12576425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A clinical study of immunological status in gastric cancer patients--with special reference to T-cell subsets in the lymphocytes of regional lymph nodes].
    Ohwada S; Takeshita M; Miyamoto Y; Izumi M
    Nihon Geka Gakkai Zasshi; 1990 Oct; 91(10):1560-6. PubMed ID: 2263239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2.
    Clayton A; Mitchell JP; Court J; Mason MD; Tabi Z
    Cancer Res; 2007 Aug; 67(15):7458-66. PubMed ID: 17671216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential regulation of IL-2 and IL-4 in patients with tobacco-related oral squamous cell carcinoma.
    Manchanda P; Sharma SC; Das SN
    Oral Dis; 2006 Sep; 12(5):455-62. PubMed ID: 16910915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression.
    Sasada T; Kimura M; Yoshida Y; Kanai M; Takabayashi A
    Cancer; 2003 Sep; 98(5):1089-99. PubMed ID: 12942579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A clinical study of immunological status in patients with gastric cancer: with special reference to T-cell subsets, interleukin-2 in the lymphocytes of peripheral blood].
    Owada S
    Nihon Geka Gakkai Zasshi; 1990 Jan; 91(1):52-61. PubMed ID: 2138244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.